PEETERS PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of PEETERS PHARMA is 2.1% (moderate). The 2024 annual accounts show equity of €2.5m and a net result of €893,642. Equity is growing by about 56% per year across the filed financial years. Its solvency ranks better than 35% of 6,482 sector peers (NACE 47, financial year 2024). The company has been active since 2007 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Part of the group
peeters mathieu management
7 companies
Group, risk and exposure
Connections & network
1 current directorThe board mandates are listed below; here you explore them as a network.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Acquisitions and mergers
11 transactionsTook over:Apotheek Peeters Ophoven NV
Took over:Apotheek Peeters Oudsbergen NV
Took over:Peeters Pharma Bornem NV
Took over:Peeters Pharma Hingene BV
Took over:Peeters Pharma Wintam BV
Took over:Pharma Louvranges BV
Took over:Pharma Wandre BV
Took over:Pharmacie Anthoine BV
Took over:Pharmacie Dumon BV
Took over:Pharmacie Eliot-Maisin BV
Took over:Pharmacie Pinoy NV